Skip to main content
Loading Events

« All Events

  • This event has passed.

Limited Submission Internal Deadline: Pathway to Stop Diabetes Award

June 21, 2022 @ 5:00 pm

Limited Submissions: Internal Call for Proposals

Pathway to Stop Diabetes Award

UNC Internal Deadline: 11:59PM, Tuesday, June 21, 2022 


*Please distribute to relevant faculty*

Key Dates

UNC Internal Deadline: 11:59pm, Tuesday, June 21, 2022

Full Application Deadline: August 1, 2022 

Important Information

Number of applications per institution: One per category.

Award Information

Initiator Award (INI): Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.

Maximum Funding: Up to $100,000/year in Phase 1, Up to $325,000/year in Phase 2

Support: Project support & PI salary
Indirect Support: Up to 10% of directs in Phase 1, Up to 30% of directs in Phase 2
Project % Effort Required: 75-100% effort in Phase 1, 50-75% effort in Phase 2

Accelerator Award (ACE): Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

Maximum Funding: $325,000/year
Support: Project support & PI salary
Indirect Support: Up to 30% of directs
Project % Effort Required: 25-50% effort


To Apply

Submit the following as attachments via LAMSeS by 11:59PM, Tuesday, June 21, 2022.

  1. Letter of Recommendation from Department Chair 
  2. PI’s NIH-formatted biosketch – co-PI biosketches may be included but are not required. 
  3. Project description + Award Category (INI or ACE) (up to 2-pages)
  4. List of potential collaborators (internal and external to UNC) 
  5. Names of three internal (to UNC) experts who could speak knowledgeably about the candidate’s research and who could potentially serve on an internal review panel. 
    • Please do not include the names of faculty named on the project, chairs, deans, directors, direct reports, or others who have a conflict of interest.
    • Please notify all potential internal reviewers before submitting the pre-proposal packet to ORD.

Program Overview

This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefitThe ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease – and the pathway to this impact is clear. Our vision is to create a pathway to launch the next generation of trailblazers in diabetes research.


Pathway to Stop Diabetes has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants, providing access to scientific and career mentoring from leading diabetes researchers, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders, whose discoveries will stop diabetes and all of its burdens once and for all.


To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes, is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management and cures. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes.


Initiator Award (INI): This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty.


Accelerator Award (ACE): This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.



Initiator Award (INI): Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support. 

Applicant: Postdoctoral Fellow

Award Term: Up to 7 years
Citizenship: Authorized to work in U.S. or U.S. possessions


Accelerator Award (ACE): Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support. 

Applicant: Early Career Faculty 

Award Term: Up to 5 years
Citizenship: Authorized to work in U.S. or U.S. possessions 


Review Criteria

The internal review criteria will mirror the guidelines as described within the full program announcement alongside the standard NIH criteria below. 

Proposal’s responsiveness to program criteria: How well the proposal addresses the program’s stated goals? How well does the nominee meet the foundation’s criteria?

Presentation of the proposal: Is the proposal well-written and easily understood? Does it anticipate, and address potential areas of weakness?

Nominee: Address the qualifications and research experience of the nominee. What is their stature in the academic community? Are they well-qualified based on the criteria? Share what is most significant (based on the foundation’s criteria) about the nominee’s publication experience, funding history, how they have made a significant contribution to science/scholarship?

Impact of the proposal and potential benefit to the university: Will the proposal make a significant impact on the academic field involved? To society? Will it advance the state-of-the-art in its field? How will the university community benefit if the proposal were funded?

Additional Information

Complete Program Announcement 


For additional information, please contact the Limited Submissions Team with questions at




Limited Submissions Team

Office of Research Development

University of North Carolina at Chapel Hill



June 21, 2022
5:00 pm